summary
Introduced
02/18/2025
02/18/2025
In Committee
02/26/2025
02/26/2025
Crossed Over
Passed
Dead
03/28/2025
03/28/2025
Introduced Session
2025 Regular Session
Bill Summary
Create a new section of KRS Chapter 218A to permit the sale or purchase of ivermectin that's been approved for human use without a prescription from a practitioner.
AI Summary
This bill creates a new section in the Kentucky Revised Statutes (KRS) Chapter 218A that would allow the sale and purchase of ivermectin, a medication originally developed to treat parasitic infections in humans and animals, without requiring a prescription from a healthcare practitioner. Currently, most medications require a prescription from a licensed medical professional, but this bill would specifically exempt ivermectin that has been approved for human use from those standard prescription requirements. The bill effectively removes the existing regulatory barrier that typically mandates a formal medical consultation before obtaining this medication, potentially making ivermectin more easily accessible to Kentucky residents. While the bill does not specify the reasons for this change, it represents a significant modification to existing pharmaceutical regulations by allowing direct over-the-counter sale of a medication that would traditionally require professional medical oversight.
Committee Categories
Health and Social Services
Sponsors (8)
T.J. Roberts (R)*,
Josh Calloway (R),
Steven Doan (R),
Thomas Huff (R),
Matt Lockett (R),
Candy Massaroni (R),
Marianne Proctor (R),
Felicia Rabourn (R),
Last Action
to Health Services (H) (on 02/26/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://apps.legislature.ky.gov/record/25RS/hb668.html |
| BillText | https://apps.legislature.ky.gov/recorddocuments/bill/25RS/hb668/orig_bill.pdf |
Loading...